---
title: "Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Morgans"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292685529.md"
description: "Morgans analyst Derek Jellinek maintained a Buy rating on Resmed Inc with a A$40.97 price target, citing his coverage of the Healthcare sector. This follows a recent Hold downgrade by Citi and a prior Buy from Jarden's Steven Wheen. The report also notes TipRanks' launch of the RANK ETF, which tracks large U.S. companies based on analyst momentum."
datetime: "2026-07-14T23:45:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292685529.md)
  - [en](https://longbridge.com/en/news/292685529.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292685529.md)
---

# Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Morgans

In a report released today, Derek Jellinek from Morgans maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, with a price target of A$40.97.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Jellinek covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, Cochlear , and CSL. According to TipRanks, Jellinek has an average return of \-8.9% and a 32.79% success rate on recommended stocks.

In addition to Morgans, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh also received a Buy from Jarden’s Steven Wheen in a report issued on July 8. However, yesterday, Citi downgraded Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: RMD) to a Hold.

### Related Stocks

- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [COH.AU](https://longbridge.com/en/quote/COH.AU.md)
- [CSL.AU](https://longbridge.com/en/quote/CSL.AU.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [CHEOY.US](https://longbridge.com/en/quote/CHEOY.US.md)
- [CSLLY.US](https://longbridge.com/en/quote/CSLLY.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [ResMed beats on earnings and ups dividend, yet shares plummet](https://longbridge.com/en/news/295180735.md)
- [ResMed announces dividend of R$ 0.57 per unit, payable Sept. 30](https://longbridge.com/en/news/295267898.md)
- [ResMed Q4 FY26 GAAP diluted EPS rises 2% to $2.64; revenue increases 9% to $1.46 billion](https://longbridge.com/en/news/295140984.md)
- [ResMed director Peter C. Farrell disposes of 8,000 common shares worth $1.8 million](https://longbridge.com/en/news/295133419.md)
- [Royal Bank of Canada Reduces Stock Holdings in ResMed Inc. $RMD](https://longbridge.com/en/news/294602242.md)